1199.52.0105 Boehringer Ingelheim Investigational Site

New Haven, Connecticut

0 studies enrolling now · 1 studies all time

What they study most

Colorectal Neoplasms

Studies at this site

• Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1) — Completed